|
Abdollah Farsoni
https://ne.oregonstate.edu/abi-t-farsoni
Abi Farsoni's research is interdisciplinary, crossing the boundaries between nuclear technology, advanced detection systems, and radiological environmental monitoring. Farsoni's primary research interests are in the ......
|
|
Adam Alani
https://pharmacy.oregonstate.edu/users/wathah-alani
The research in my lab revolves around the designing biocompatible, biodegradable therapeutic polymers for specific disease states. I believe that nanotherapeutics, utilizing smart drug delivery systems offers us new and innovative ways to treat disease states w......
|
|
Adrian Gombart
Our research is focused on understanding the regulation of antimicrobial peptide expression by the vitamin D pathway. When immune cells called macrophages encounter a pathogen and become activated, the vitamin D pathway is turned on, leading to the induction of the cathelicidin antimicrobial peptide if serum levels of vitamin D are sufficient. We have shown that this mechanism is conserved in humans and primates but not in other mammals. Therefore, we developed a transgenic mouse that carries......
|
|
Aleksandra Sikora
Aleksandra Sikora, PhD. Associate Professor of Pharmacoproteomics in the College of Pharmacy at Oregon State University (Corvallis, Oregon, USA) is a microbiologist with experience in bacterial pathogenesis, proteomics, and high-throughput screening for identification of new antimicrobials. She currently focuses on proteomics-driven antigen mining to develop gonorrhea vaccine(s) as well as identification of new antibiotics targeting drug-resistant bacterial infections.
Dr. Sikora rece......
|
|
Angelo Gomez
Angelo Gomez joined Oregon State University in 1996. As Interim Executive Director, Angelo is responsible for managing all aspects of the University’s Equity and Inclusion Plan and ensuring the effectiveness of equity and inclusion programs. Angelo is also responsible for coordinating the University’s obligations under the Americans with Disabilities Act. Additionally he is involved in investigating and......
|
|
Arup Indra
Cell signaling, skin development, stem cell biology, inflammatory skin disease, melanoma, tumor microenvironment, Mouse genetics, and transcriptional regulation.
Our laboratory is investigating into the mechanisms of skin development in space and time from stem cells using mouse genetic......
|
|
Canan Schumann
|
|
Carla Schubiger
|
|
Chrissa Kioussi
Chrissa
Kioussi investigates the molecular strategies responsible for organ development
and regeneration. Her work has uncovered roles of genes that regulate cell
fate, organ architecture and body homeostasis. She uses mouse models to understand the molecular
mechanisms and signals that embryos normally use to make muscle. These
strategies link regulated gene response to other cellular response systems during ......
|
|
David Hamby
Dr. Hamby received his B.S. in Physics(w/honors) from Mercer University in 1984. He received his M.S. in Health Physics from University of North Carolina, Chapel Hill in 1986. He received his Ph.D. in Health Physics, University of North Carolina, Chapel Hill in 1989.
Dr. Hamby has been at OSU since 1999 and is currently ......
|
|
David Chan
|
|
David Wong
|
|
Douglas Goeger
|
|
Dwi Andreas Santosa
|
|
Edward Cazalas
|
|
Gitali Indra
|
|
Hui Xu
|
|
James White
My research program blends studies of synthetic methods with the total synthesis of natural products and other complex molecules. The goal of our work is to develop new strategies in synthesis and then apply them to the elaboration of targets where particular structural features present a significant challenge.
|
|
Jesse Terry
|
|
Jongtae Yang
|
|
Joseph Beckman
|
|
Joseph Abecassis
|
|
Josiah Moses
|
|
Kerry Mcphail
|
|
Konstantin Korotkov
|
|
Linquan Bai
|
|
Luiz Bermudez
The laboratory of Dr. Bermudez is interested in the mechanisms of the pathogenesis of intracellular bacteria, with focus on mycobacteria. Mycobacteria are a common cause of infections in humans and animals. Mycobacterium tuberculosis infects a third of the world population and is responsible for 3 million deaths annually. Mycobacterium avium, an environmental bacterium, commonly causes disseminated disease in patients with Acquired Immu......
|
|
Mark Leid
|
|
Milan Milovancev
|
|
Niran Roongsawang
|
|
Norifumi Shirasaka
|
|
Oleh Taratula
https://pharmacy.oregonstate.edu/users/oleh-taratula
Dr. Oleh Taratula received his M.S. degree from Ivan Franko National University of Lviv in Ukraine. He received his Ph.D. from Rutgers University. He currently serves as an Assistant Professor in the Oregon State College of Pharmacy, Department of Pharmaceutical Sciences. Dr. Taratula's research int......
|
|
Olena Taratula
https://pharmacy.oregonstate.edu/users/olena-taratula
Dr. Olena Taratula received her M.S. degree from Ivan Franko National University of Lviv in Ukraine. She received her Ph.D. from Rutgers University. She currently serves as an Associate Professor in the Oregon State College of Pharmacy at the Department of Pharmaceutical Sciences. Dr. Taratula's c......
|
|
Pamela Beilby
|
|
Patricia Flatt
|
|
Philip Proteau
|
|
Rajan Juniku
|
|
Ravi Balasubramanian
|
|
Rebecca Medina
|
|
Robert Blizzard
|
|
Ryan Mehl
Dr.
Mehl obtained his Ph.D. in organic chemistry from Cornell University and
postdoctoral position with Professor Schultz at Scripps Research Institute. He
earned tenure and Associate Professor while developing a biochemistry program
at Franklin & Marshall College from 2002-2011. In 2011 Dr. Mehl became
Associate Professor at Oregon State University and Director of the worlds first
Unnatural Protein Facil......
|
|
Sarah Nemanic
|
|
Susan Moobery
|
|
T. Mark Zabriskie
Dr. Zabriskie is the dean of the College of Pharmacy at Oregon State University. Research in his laboratory focuses on the biosynthesis of nonribosomal peptide and peptidyl nucleoside antibiotics. All of the compounds being studied are effective in treating various drug resistant bacterial infections and most are produced by Streptomyces spp. soil bacteria. Representative target compounds include the antitubercular......
|
|
Taifo Mahmud
|
|
Takuya Ito
|
|
Taymaz Homayouni
|
|
Todd Capson
|
|
Tory Hagen
|
|
William Gerwick
|
|
Zixin Deng
|